title: [The value and drawbacks of evaluation of the risk of fetal trisomy 21].
authors.affiliation: Service de Biochimie et d'Hormonologie, Hôpital Antoine-Béclère, Clamart.
authors.forename: J
authors.initials: J
authors.lastname: Taieb
authors.forename: C
authors.initials: C
authors.lastname: Benattar
authors.forename: F
authors.initials: F
authors.lastname: Audibert
authors.forename: R
authors.initials: R
authors.lastname: Frydman
authors.forename: A
authors.initials: A
authors.lastname: Lindenbaum
mesh_terms: D015415:Biomarkers / Q000032:analysis; D004314:Down Syndrome / Q000175:diagnosis* / Q000523:psychology; D005260:Female; D005315:Fetal Diseases / Q000175:diagnosis* / Q000523:psychology; D005326:Fetal Proteins / Q000032:analysis; D006801:Humans; D007603:Jurisprudence; D008423:Maternal Age; D011247:Pregnancy / Q000523:psychology; D011257:Pregnancy Proteins / Q000032:analysis; D011296:Prenatal Diagnosis / Q000523:psychology; D012307:Risk Factors; D016216:Ultrasonography, Prenatal
chemical_list: D015415:Biomarkers; D005326:Fetal Proteins; D011257:Pregnancy Proteins